logo
Plus   Neg
Share
Email

Supernus Pharmaceuticals Prices Its IPO In The Range Of $12-$14 Per Share

Supernus Pharmaceuticals Wednesday announced that it has filed Form S-1 with the Securities and Exchange Commission or the SEC revealing the pricing of its initial public offering for 5,769,000 shares of common stock.

The company revealed that it anticipates to price the initial public offering to be between $12.00 and $14.00 per share of common stock.

The company further added that it has granted the underwriters an option to purchase up to 865,350 additional shares of common stock to cover over-allotments.

The company stated that itsd shares would be listed on the Nasdaq Global Market under the symbol "SUPN."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Down the line, GE has transformed from a too-big-to-fail conglomerate to a too-big-for-success albatross. The company has admitted to being too-much focused on EPS and operating profit, and not paying enough attention to cash. However, GE is certainly learning lessons from its past and refocusing its strategies to stage a comeback to its Camelot days, the key catalysts being... Industrial conglomerate General Electric Co., one of the original components of the Dow Jones Industrial Average, has been replaced by Walgreens Boots Alliance Inc. in the blue-chip index. The change comes into effect prior to the open of trading on Tuesday, June 26. The 122-year-old Dow Jones Industrial Average, or simply the Dow, is a stock market index with 30 component companies. A $716 billion defense policy bill easily cleared the Senate on Monday, although the legislation must still be reconciled with the version previously approved by the House. The Senate voted 85 to 10 in favor of the National Defense Authorization Act, which authorizes U.S. military spending for fiscal 2019.
Follow RTT